← Back to headlines
Bristol-Myers Squibb Stock at Risk From Proposed Medicare Drug Price Negotiation Updates
Bristol-Myers Squibb Company (BMY) stock faces potential risks due to proposed updates concerning Medicare drug price negotiations.
30 Jun, 13:07 — 30 Jun, 13:07
Sources
Showing 1 of 1 sources
Related Stories
Police Disperse Mob That Burned Migrant Camp in Spanish Enclave of Ceuta
12m ago
Magnitude 6 Quake Strikes Gulf of Aden While Magnitude 5 Tremor Hits Tibet
22m ago
Iran Sets Conditions for Reopening Strait of Hormuz as Qatar Mediates Tensions
30m ago
Ukrainian Authorities Urge Evacuation of Kherson Amid Intensifying Russian Attacks
39m ago